Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate. (Q46035627)
Jump to navigation
Jump to search
scientific article published on 26 April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate. |
scientific article published on 26 April 2009 |
Statements
1 reference
Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate. (English)
1 reference
Punit H Marathe
1 reference
Amrita V Kamath
1 reference
Yueping Zhang
1 reference
Celia D'Arienzo
1 reference
Rajeev Bhide
1 reference
Joseph Fargnoli
1 reference
26 April 2009
1 reference
65
1 reference
55-66
1 reference
1
1 reference
Identifiers
1 reference
1 reference